Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin vs Glimepiride for Nocturnal Hypoglycemia in T2DM
NCT02373865Phase 4Terminated
- Sponsor
- GWT-TUD
- Start
- Sep 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by GWT-TUD. Started Sep 2015; status: terminated.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02373865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02373865.